| Similar Articles |
|---|
 |
The Motley Fool
June 17, 2010
Todd Wenning |
One Smart Way to Buy Bank Stocks One area of the banking sector that we have been watching -- and buying -- for some time is smaller regional banks.   |
The Motley Fool
December 1, 2011
Selena Maranjian |
Make Money in Recovering Financial Stocks the Easy Way If you expect banks and financial services companies to get their acts together and thrive in the years ahead, the Vanguard Financials ETF could save you a lot of trouble. |
The Motley Fool
December 21, 2011
Selena Maranjian |
Make Money in Recovering Bank Stocks the Easy Way The SPDR KBW Bank ETF could save you a lot of trouble. |
Financial Advisor
April 2009
Marla Brill |
Tapping ETFs Dividend-rich ETFs may boost returns when the market is treading water. |
Financial Advisor
October 2011
Marla Brill |
On The Defense Plain-vanilla sectors are leading the ETF pack. |
The Motley Fool
August 22, 2011
Amanda B. Kish |
How to Lose Money in a Volatile Market Unless you want to lose a lot more money from trying to time the market, don't flee stocks when the going gets rough. |
The Motley Fool
August 18, 2009
Dan Caplinger |
The Easy Way to Find Big Dividends Choosing a solid dividend ETF can help you diversify your portfolio while giving you the benefits that dividend-payers offer. |
The Motley Fool
September 7, 2011
Selena Maranjian |
Make Money in Regional Bank Stocks the Easy Way There's no need to guess which regional bank will do best with the SPDR KBW Regional Banking ETF. |
The Motley Fool
January 30, 2006
Stephen D. Simpson |
Healing Growth for Kinetic Concepts Reimbursement and competition are becoming bigger threats, but the wound-care specialist is still a leader in a large market. Investors may want to put this one high up on their watch lists. |
The Motley Fool
January 25, 2011
Selena Maranjian |
Make Money in Banks the Easy Way There's no need to guess which banks will perform best with the SPDR KBW Bank ETF. |
The Motley Fool
May 24, 2010
Todd Wenning |
The Best Dividend Stocks of the Decade Looking back so we can move forward. |
The Motley Fool
October 17, 2011
Selena Maranjian |
Make Money in High-Yield Stocks the Easy Way If you expect stocks with solid dividend yields to reward shareholders over the long term, the Vanguard High Dividend Yield Index ETF could save you a lot of trouble. |
The Motley Fool
July 1, 2010
Alex Dumortier |
3 Stocks and 3 ETFs to Salvage 2010 Investing after a tough first half. |
IndustryWeek
December 16, 2009 |
IW50 Profile: Kinetic Concepts -- How Kinetic Concepts Stays Healthy Medical products manufacturer has a strategy for thriving during tough economic times. |
The Motley Fool
October 27, 2008
Zoe Van Schyndel |
Get More Money From Your Investments One ETF that actively seeks out stocks with long records of paying dividends, the State Street SPDR Dividend ETF, may be interesting to investors in these turbulent times. |
The Motley Fool
February 17, 2010
Selena Maranjian |
Investments for the Indecisive Can't make up your mind? ETFs might help. |
The Motley Fool
March 29, 2011
Michael Johnston |
Dividend ETF Investing: Mid-Cap Options These dividend paying ETFs are worth a look. |
The Motley Fool
May 27, 2010
Rich Smith |
This Just In: Upgrades and Downgrades Brigantine recommends purchase of Kinetic Concepts in the medical products arena. |
The Motley Fool
June 14, 2010
Todd Wenning |
One of the Riskiest Investments You Can Make You can make money buying shares of well-run companies; there just needs to be another factor the market is missing, in order for you to buy them at the right price. |
The Motley Fool
October 25, 2011
Dan Caplinger |
4 ETFs You Can Count On Hundreds of ETFs could go away soon, but these will continue on. |
The Motley Fool
February 11, 2008
Sham Gad |
Buffett Speaks on the Credit Crunch Read on for some flawless wisdom from Warren Buffett regarding the current credit turmoil. |
The Motley Fool
February 8, 2008
Brian Lawler |
Hold on to GlaxoSmithKline This might be a tough year for the big pharma company, but its pipeline makes it a keeper. |
The Motley Fool
September 2, 2010
Nathan Alderman |
What's the Best ETF Right Now? We poll a panel of Fools for their finest fund picks. |
The Motley Fool
October 14, 2010
Alex Dumortier |
3 Must-Own Sectors in This Market Don't own the market wholesale. |
Financial Advisor
October 2008
Marla Brill |
Ready For Harvest Rounding up investment laggards to harvest tax losses is a good idea toward the end of any year in taxable accounts, but this year there is added incentive. |
The Motley Fool
September 10, 2009
Jennifer Schonberger |
Expert Summit: How to Invest Right Now Top financial experts on their favorite sectors and companies. |
The Motley Fool
September 25, 2008
Dan Caplinger |
Watch Out for Broken ETFs Government action sometimes has unintended consequences. |
The Motley Fool
March 14, 2011
Selena Maranjian |
Make Money in Industrials the Easy Way A well-chosen ETF can grant you instant diversification across the industrial industry. |
The Motley Fool
May 27, 2010
Jim Royal |
Buffett's a Dividend Investor, Why Aren't You? Follow the Oracle's lead here. |
The Motley Fool
October 18, 2011
Selena Maranjian |
Make Money in All the Dow Stocks the Easy Way If you expect the 30 stocks in the Dow, which represent some of our nation's biggest and most vital companies, to thrive over the long term, the SPDR Dow Jones Industrial Average ETF could save you a lot of trouble. |
The Motley Fool
November 9, 2006
Brian Lawler |
The Best Blue Chip for 2007: GlaxoSmithKline Here's a blue-chip pharma stock for your portfolio. |
The Motley Fool
March 25, 2011
Dan Caplinger |
This China Play Is a Better Bet Different Chinese ETFs have different levels of risk. Pick the one that's right for you. |
The Motley Fool
July 23, 2010
Eric Dutram |
Friday's ETF to Watch: European Financials ETF (EUFN) Are European banks unstable? |
The Motley Fool
February 3, 2011
Owain Bennallack |
Glaxo Sweetens a Bitter Pill The drugmaker reports a loss, but resumes share buybacks. |
The Motley Fool
April 28, 2008
Brian Lawler |
Glaxo Getting By Weakening currency barely redeems the pharmaceutical's Q1 numbers. |
